logo-loader

Proactive news snapshot: BlueRock Diamonds, Providence Resources, Integumen

A glance at some of the day's highlights from the Proactive Investors newswire

news
Your daily round-up from the world of Proactive

BlueRock Diamonds PLC (LON:BRD) has achieved record grades and production from the Kareevlei diamond mine in South Africa. Some 3,516 carats were produced after the amount of tonnes processed in its second quarter rose 130% to 78,759 tonnes at a grade of 4.46 carats per tonne (cpht). 

Providence Resources PLC (LON:PVR) told investors it has received communication from HSBC regarding a US$10mln transfer of funds via joint venture partner APEC.

Integumen PLC’s (LON:SKIN) revenues soared by over 1,000% in the first half of the year as blue-chip customers continue to sign up for its cosmetics testing services. 

appScatter Group PLC (LON:APPS) has expanded its Priori Data brand into Asia after signing a joint venture (JV) with Japanese on-demand internet consultancy interarrows Inc. The app management and data intelligence group said the JV would initially base its Priori Data platform in Japan, which boasts one of the world’s largest app markets valued at around US$13.7bn in 2017.

Impax Asset Management Group PLC (LON:IPX) saw the value of its assets under management (AUM) rise by 10% in the April-June quarter.

Corero Network Security PLC (LON:CNS), the network security company, has bagged new orders worth US$1mln. 

Braveheart Investment Group PLC (LON:BRH) shares advaqnced on Monday after it purchased a 33% stake in Pharm2Farm Limited (P2F), a plant nutrients firm. 

Premier African Minerals Ltd (LON:PREM) has agreed to lend US$1.35mln to MN Holdings Ltd, the owner and operator  of the Otjozondu manganese mining project in Namibia.

Active Energy Group PLC (LON:AEG), the biomass-based renewable energy business, has raised £3.44mln through a loan note issue. 

Chaarat Gold Holdings Ltd (LON:CGH) has waived the requirement for major shareholder Labro to make a mandatory offer for the company on the acquisition of a further 4mln shares. Labro already holds 139,841,969 shares, amounting to approximately 34.8 per cent of Chaarat's issued share capital. 

Pensana Metals Ltd (ASX:PM8) has hit high grade intersections at the Longonjo neodymium-praseodymium project located in an infrastructure-rich region of Angola. 

Block Energy PLC (LON:BLOE) has secured the equipment for its next phase of drilling at the highly prospective West Rustavi prospect. 

Anglo African Oil & Gas PLC (LON:AAOG) has highlighted to investors that it has received multiple new funding offers, and, a competitive process is now underway. 

SDX Energy Plc (LON:SDX) told investors that the South Disouq field development continues on schedule and on budget. 

Physiomics Plc (LOB:PYC), developer of the virtual tumour software platform, has landed a deal with Bicycle Therapeutics and Cancer Research UK (CRUK). 

BATM Advanced Communications Ltd (LON:BVC) said it expects to join the premier TA-90 index after its shares debut on the Tel Aviv Stock Exchange (TASE) on Thursday (July 11). 

Greatland Gold PLC (LON:GGP) has found gold nuggets along a longer stretch of its Panorama project in Western Australia and geochemical and geophysical work is continuing to further extend the known area of mineralisation.

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Chaarat Gold Holdings Ltd named herein, including the promotion by the Company of Chaarat Gold Holdings Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Scancell back in the clinic with a phase II trial of its...

Scancell Holdings PLC's (LON:SCLP) Cliff Holloway tells Proactive London's Andrew Scott they've begun the UK arm of the phase II trial of its flagship skin cancer treatment. The trial is testing the safety and efficacy of SCIB1 in metastatic melanoma patients who are also receiving Merck’s...

5 hours, 36 minutes ago

RNS

Issuance of shares in Company

3 days, 12 hours ago

US$10m Loan Update

5 days, 12 hours ago

Webcast replay

2 weeks, 4 days ago

Conference call and webcast

2 weeks, 5 days ago

Agreement with Polymetal

2 weeks, 6 days ago

Results of Annual General Meeting

3 weeks, 3 days ago

3 min read